We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BrainsGate Ischemic Stroke System Awaits Advisory Panel Review
BrainsGate Ischemic Stroke System Awaits Advisory Panel Review
Israel-based BrainsGate’s ischemic stroke treatment device will face a vote of the FDA’s Neurological Devices Panel of the Medical Devices Advisory Committee, which will meet on Dec. 10 to decide whether to recommend that the agency approve the company’s premarket application.